Exerts an Anticancer Effect on Human Osteosarcoma Cells via Suppressing the Wnt/β-Catenin Signaling Pathway
Background: Current treatment of osteosarcoma is limited in part by side effects and low tolerability, problems generally avoided with traditional Chinese medicine. Ganoderma lucidum , a traditional Chinese medicine with antitumor effects, offers a potential alternative, but little is known about it...
Main Authors: | Qi-Hao Zhang MD, Qin-Xiao Hu MD, Da Xie MD, Bo Chang MD, Hou-Guang Miao MD, Yun-Guo Wang MD, De-Zhong Liu MD, Xue-Dong Li MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-12-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/1534735419890917 |
Similar Items
-
PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer
by: Boning Xia MD, et al.
Published: (2020-05-01) -
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo
by: Junli Chang, et al.
Published: (2017-08-01) -
Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis
by: Twan J. J. de Winter, et al.
Published: (2021-02-01) -
Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis
by: Fengxiang Pang, et al.
Published: (2023-03-01) -
Identification of Prognostic RBPs in Osteosarcoma
by: Bei Li MD, et al.
Published: (2021-03-01)